Author:
Liu Shengyan,Yu Yanying,Liu Yuchen,Ma Mingwei,Li Chen
Funder
National Natural Science Foundation of China
Reference6 articles.
1. New insights in the treatment of SAPHO syndrome and medication recommendations;Cheng;J Inflamm Res,2022
2. A case of SAPHO syndrome complicated by uveitis with good response to both TNF inhibitor and JAKinib;Baisya;Case Rep Rheumatol,2023
3. SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report;Yuan;Front Immunol,2022
4. Successful treatment of hip involvement in SAPHO syndrome with baricitinib;Wuriliga;Rheumatol Adv Pract,2022
5. A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro;Murakami;PLoS One,2017